Duration of Antiviral Prophylaxis and Risk of Herpes Zoster among Patients Receiving Autologous Hematopoietic Stem Cell Transplants: A Retrospective, Observational Study.

Dongmu ZhangThomas WeissYu FengLynn Finelli

Published in: Advances in therapy (2017)

Auto-HSCT patients are at increased risk for HZ, even when prescribed AP. A safe and effective vaccine against HZ for auto-HSCT patients could be a useful adjunctive prevention strategy.

Keyphrases

end stage renal disease
hematopoietic stem cell
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
bone marrow
patient reported outcomes
mesenchymal stem cells
cell therapy
patient reported